Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.

RATIONALE Long-term survival after lung transplantation is limited by infectious complications and by bronchiolitis obliterans syndrome (BOS), a form of chronic rejection linked in part to microbial triggers. OBJECTIVES To define microbial populations in the respiratory tract of transplant patients comprehensively using unbiased high-density sequencing. METHODS Lung was sampled by bronchoalveolar lavage (BAL) and upper respiratory tract by oropharyngeal wash (OW). Bacterial 16S rDNA and fungal internal transcribed spacer sequencing was used to profile organisms present. Outlier analysis plots defining taxa enriched in lung relative to OW were used to identify bacteria enriched in lung against a background of oropharyngeal carryover. MEASUREMENTS AND MAIN RESULTS Lung transplant recipients had higher bacterial burden in BAL than control subjects, frequent appearance of dominant organisms, greater distance between communities in BAL and OW indicating more distinct populations, and decreased respiratory tract microbial richness and diversity. Fungal populations were typically dominated by Candida in both sites or by Aspergillus in BAL but not OW. 16S outlier analysis identified lung-enriched taxa indicating bacteria replicating in the lower respiratory tract. In some cases this confirmed respiratory cultures but in others revealed enrichment by anaerobic organisms or mixed outgrowth of upper respiratory flora and provided quantitative data on relative abundances of bacteria found by culture. CONCLUSIONS Respiratory tract microbial communities in lung transplant recipients differ in structure and composition from healthy subjects. Outlier analysis can identify specific bacteria replicating in lung. These findings provide novel approaches to address the relationship between microbial communities and transplant outcome and aid in assessing lung infections.

[1]  R. Knight,et al.  Bacterial Community Variation in Human Body Habitats Across Space and Time , 2009, Science.

[2]  P. Corris,et al.  Targeting Allograft Injury and Inflammation in the Management of Post‐Lung Transplant Bronchiolitis Obliterans Syndrome , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  J. Maurer Respiratory Viral Infections Are a Distinct Risk for Bronchiolitis Obliterans Syndrome and Death , 2006 .

[4]  P. Dartevelle,et al.  Impairment of bronchial mucociliary clearance in long-term survivors of heart/lung and double-lung transplantation. The Paris-Sud Lung Transplant Group. , 1993, Chest.

[5]  Robert K. Colwell,et al.  A new statistical approach for assessing similarity of species composition with incidence and abundance data , 2004 .

[6]  Paramvir S. Dehal,et al.  FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments , 2010, PloS one.

[7]  J. Gower Generalized procrustes analysis , 1975 .

[8]  M. Dietrich,et al.  Patterns of Mycobacterium avium Culture and PCR Positivity in Immunodeficient HIV-infected Patients: Progression from Localized to Systemic Disease , 1997 .

[9]  Eoin L. Brodie,et al.  Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. , 2010, Environmental microbiology.

[10]  R. Cattell,et al.  The Procrustes Program: Producing direct rotation to test a hypothesized factor structure. , 2007 .

[11]  Patrick M. Gillevet,et al.  Characterization of the Oral Fungal Microbiome (Mycobiome) in Healthy Individuals , 2010, PLoS pathogens.

[12]  Fang Liu,et al.  Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis , 2010, BMC Genomics.

[13]  B. Haas,et al.  Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. , 2011, Genome research.

[14]  N. Pace,et al.  Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis , 2007, Proceedings of the National Academy of Sciences.

[15]  H. Monteil,et al.  Peripartum Bacteremias Due to Leptotrichia amnionii and Sneathia sanguinegens, Rare Causes of Fever during and after Delivery , 2004, Journal of Clinical Microbiology.

[16]  G. Snell,et al.  Chlamydia pneumoniae Serology in Donors and Recipients and the Risk of Bronchiolitis Obliterans Syndrome after Lung Transplantation , 2005, Transplantation.

[17]  Vanja Klepac-Ceraj,et al.  Comparative Analyses of the Bacterial Microbiota of the Human Nostril and Oropharynx , 2010, mBio.

[18]  G. Verleden,et al.  A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation , 2010, European Respiratory Journal.

[19]  J. Orens,et al.  Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. , 2003, American journal of respiratory and critical care medicine.

[20]  D. Schwartz,et al.  Genetic Regulation of Rejection and Survival Following Human Lung Transplantation by the Innate Immune Receptor CD14 , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  Eoin L. Brodie,et al.  Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients , 2010, PloS one.

[22]  P. Jaccard THE DISTRIBUTION OF THE FLORA IN THE ALPINE ZONE.1 , 1912 .

[23]  Eoin L. Brodie,et al.  Loss of Bacterial Diversity during Antibiotic Treatment of Intubated Patients Colonized with Pseudomonas aeruginosa , 2006, Journal of Clinical Microbiology.

[24]  A. Rahmel,et al.  The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report--2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  J. Curtis,et al.  Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD , 2011, PloS one.

[26]  G. Darling,et al.  Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. , 2005, The Journal of thoracic and cardiovascular surgery.

[27]  V. Karthaus,et al.  Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[28]  R. Lowry,et al.  The cough response to ultrasonically nebulized distilled water in heart-lung transplantation patients. , 1989, The American review of respiratory disease.

[29]  A. Rahmel,et al.  The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report--2011. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  David Artis,et al.  Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis , 2009, Mucosal Immunology.

[31]  D. Schwartz,et al.  Innate immunity influences long-term outcomes after human lung transplant. , 2005, American journal of respiratory and critical care medicine.

[32]  B S Weir,et al.  Estimating F-statistics. , 2002, Annual review of genetics.

[33]  Hongzhe Li,et al.  Disordered Microbial Communities In The Upper Respiratory Tract Of Cigarette Smokers , 2011, ATS 2011.

[34]  Kyle Bittinger,et al.  Topographical continuity of bacterial populations in the healthy human respiratory tract. , 2011, American journal of respiratory and critical care medicine.

[35]  R. Knight,et al.  Quantitative and Qualitative β Diversity Measures Lead to Different Insights into Factors That Structure Microbial Communities , 2007, Applied and Environmental Microbiology.

[36]  J. Belperio,et al.  Lung transplantation: infection, inflammation, and the microbiome , 2011, Seminars in Immunopathology.

[37]  Lior Pachter,et al.  Disordered Microbial Communities in Asthmatic Airways , 2010, PloS one.

[38]  V. Valentine,et al.  Infections in lung allograft recipients: ganciclovir era. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[39]  R. Elashoff,et al.  Aspergillus Colonization of the Lung Allograft Is a Risk Factor for Bronchiolitis Obliterans Syndrome , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[40]  G. Tian,et al.  Dirichlet and Related Distributions: Theory, Methods and Applications , 2011 .

[41]  M. Collins,et al.  Characterization of some strains from human clinical sources which resemble "Leptotrichia sanguinegens": description of Sneathia sanguinegens sp. nov., gen. nov. , 2001, Systematic and applied microbiology.

[42]  W. V. van Son,et al.  Association Between Donor MBL Promoter Haplotype and Graft Survival and the Development of BOS After Lung Transplantation , 2008, Transplantation.

[43]  P. Corris,et al.  Pseudomonas aeruginosa Colonization of the Allograft After Lung Transplantation and the Risk of Bronchiolitis Obliterans Syndrome , 2008, Transplantation.

[44]  P. Gajer,et al.  Vaginal microbiome of reproductive-age women , 2010, Proceedings of the National Academy of Sciences.

[45]  Shu-sen Lin,et al.  Assessing oropharyngeal dysphagia after lung transplantation: altered swallowing mechanisms and increased morbidity. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[46]  G. Patterson,et al.  Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[47]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[48]  D Heng,et al.  Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[49]  J. Maurer Pseudomonas aeruginosa Colonization of the Allograft After Lung Transplantation and the Risk of Bronchiolitis Obliterans Syndrome , 2009 .

[50]  J. Bartlett,et al.  Should fiberoptic bronchoscopy aspirates be cultured? , 2015, The American review of respiratory disease.